BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1071005 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)C(CNC(=O)OC(C)(C)C)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C50H58FN3O11/c1-29-21-39-38-14-12-34-23-36(55)17-19-47(34,5)49(38,51)40(56)24-48(39,6)50(29,62)41(57)28-64-43(59)16-15-42(58)63-27-30-7-9-31(10-8-30)37(26-53-45(61)65-46(2,3)4)44(60)54-35-13-11-33-25-52-20-18-32(33)22-35/h7-11,13,17-20,22-23,25,29,37-40,56,62H,12,14-16,21,24,26-28H2,1-6H3,(H,53,61)(H,54,60)/t29-,37?,38+,39+,40+,47+,48+,49+,50+/m1/s1 UEQBOLNXUTWGTF-JZEZQCBBSA-N 511466 US11059789, Example 4::US11691950, Example 4 Tumor necrosis factor Homo sapiens 230 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511466&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436330 459628724 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071006 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)C(CCNC(=O)OC(C)(C)C)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C51H60FN3O11/c1-30-23-40-39-14-12-35-25-37(56)17-20-48(35,5)50(39,52)41(57)26-49(40,6)51(30,63)42(58)29-65-44(60)16-15-43(59)64-28-31-7-9-32(10-8-31)38(19-22-54-46(62)66-47(2,3)4)45(61)55-36-13-11-34-27-53-21-18-33(34)24-36/h7-11,13,17-18,20-21,24-25,27,30,38-41,57,63H,12,14-16,19,22-23,26,28-29H2,1-6H3,(H,54,62)(H,55,61)/t30-,38?,39+,40+,41+,48+,49+,50+,51+/m1/s1 MSIJHDSLZXTECH-PUNRVMSMSA-N 511467 US11059789, Example 11::US11691950, Example 11 Tumor necrosis factor Homo sapiens 429 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511467&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146440332 459628725 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071007 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)C(CCN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H52FN3O9/c1-27-20-37-36-11-9-32-22-34(51)14-17-43(32,2)45(36,47)38(52)23-44(37,3)46(27,57)39(53)26-59-41(55)13-12-40(54)58-25-28-4-6-29(7-5-28)35(15-18-48)42(56)50-33-10-8-31-24-49-19-16-30(31)21-33/h4-8,10,14,16-17,19,21-22,24,27,35-38,52,57H,9,11-13,15,18,20,23,25-26,48H2,1-3H3,(H,50,56)/t27-,35?,36+,37+,38+,43+,44+,45+,46+/m1/s1 GUTVQHWPCMVMML-SNLRXKSYSA-N 511468 US11059789, Example 12::US11691950, Example 12 Tumor necrosis factor Homo sapiens 90.5 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511468&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436258 459628726 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071008 CC(C)(C)OC(=O)NC[C@@H](C(=O)Nc1ccc2cnccc2c1)c1ccc(COC(=O)CCC(=O)OCC(=O)[C@@]2(O)CC[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)cc1 InChI=1S/C49H57N3O11/c1-46(2,3)63-45(59)51-26-37(44(58)52-34-12-10-32-25-50-21-18-31(32)22-34)30-8-6-29(7-9-30)27-61-41(56)14-15-42(57)62-28-40(55)49(60)20-17-38-36-13-11-33-23-35(53)16-19-47(33,4)43(36)39(54)24-48(38,49)5/h6-10,12,16,18-19,21-23,25,36-39,43,54,60H,11,13-15,17,20,24,26-28H2,1-5H3,(H,51,59)(H,52,58)/t36-,37+,38-,39-,43+,47-,48-,49-/m0/s1 RJKPJPWVZSJWGK-OIODLPNCSA-N 511469 US11059789, Example 14::US11691950, Example 14 Tumor necrosis factor Homo sapiens 620 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511469&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436145 459628727 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071009 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1cccc(c1)[C@@H]1C[C@H]1C(=O)Nc1ccc2cnccc2c1F InChI=1S/C42H42F2N2O7/c1-22-15-32-31-9-8-26-17-27(47)11-13-39(26,2)41(31,44)34(48)19-40(32,3)42(22,52)35(49)21-53-38(51)24-6-4-5-23(16-24)29-18-30(29)37(50)46-33-10-7-25-20-45-14-12-28(25)36(33)43/h4-7,10-14,16-17,20,22,29-32,34,48,52H,8-9,15,18-19,21H2,1-3H3,(H,46,50)/t22-,29+,30-,31+,32+,34+,39+,40+,41+,42+/m1/s1 RWLVGLOMZNKUNE-SKZGZVCGSA-N 511470 US11059789, Example 91::US11691950, Example 91 Tumor necrosis factor Homo sapiens 102 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511470&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 160748218 459628728 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071010 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1cccc(c1)[C@@H]1C[C@H]1C(=O)Nc1ccc2cnccc2c1 InChI=1S/C42H43FN2O7/c1-23-15-34-33-10-8-28-18-30(46)11-13-39(28,2)41(33,43)35(47)20-40(34,3)42(23,51)36(48)22-52-38(50)26-6-4-5-25(16-26)31-19-32(31)37(49)45-29-9-7-27-21-44-14-12-24(27)17-29/h4-7,9,11-14,16-18,21,23,31-35,47,51H,8,10,15,19-20,22H2,1-3H3,(H,45,49)/t23-,31+,32-,33+,34+,35+,39+,40+,41+,42+/m1/s1 NJWSVCPJWIGNCK-MOKOAAJLSA-N 511471 US11059789, Example 90::US11691950, Example 90 Tumor necrosis factor Homo sapiens 300 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511471&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146423357 459628729 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071011 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)C(N(C)C)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H52FN3O9/c1-27-20-36-35-13-11-32-22-34(51)16-18-43(32,2)45(35,47)37(52)23-44(36,3)46(27,57)38(53)26-59-40(55)15-14-39(54)58-25-28-6-8-29(9-7-28)41(50(4)5)42(56)49-33-12-10-31-24-48-19-17-30(31)21-33/h6-10,12,16-19,21-22,24,27,35-37,41,52,57H,11,13-15,20,23,25-26H2,1-5H3,(H,49,56)/t27-,35+,36+,37+,41?,43+,44+,45+,46+/m1/s1 FPOMHYBUZWXMID-UXKMKUFWSA-N 511472 US11059789, Example 20::US11691950, Example 20 Tumor necrosis factor Homo sapiens 144 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511472&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436251 459628730 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071012 CN(C)C(C(=O)Nc1ccc2cnccc2c1)c1ccc(COC(=O)CCC(=O)OCC(=O)[C@@]2(O)CC[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)cc1 InChI=1S/C45H51N3O9/c1-43-18-15-33(49)22-31(43)10-12-34-35-16-19-45(55,44(35,2)23-36(50)40(34)43)37(51)26-57-39(53)14-13-38(52)56-25-27-5-7-28(8-6-27)41(48(3)4)42(54)47-32-11-9-30-24-46-20-17-29(30)21-32/h5-9,11,15,17-18,20-22,24,34-36,40-41,50,55H,10,12-14,16,19,23,25-26H2,1-4H3,(H,47,54)/t34-,35-,36-,40+,41?,43-,44-,45-/m0/s1 HKKMDATZSXPGQM-OMUKMMIFSA-N 511473 US11059789, Example 21::US11691950, Example 21 Tumor necrosis factor Homo sapiens 1650 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511473&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436178 459628731 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071013 CN(C)C(C(=O)Nc1ccc2cnccc2c1)c1ccc(COC(=O)CCC(=O)OCC(=O)[C@@]23OC(C)(C)O[C@@H]2C[C@H]2[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]32C)cc1 InChI=1S/C48H53F2N3O10/c1-44(2)62-39-22-33-34-21-36(49)35-20-32(54)15-17-45(35,3)47(34,50)37(55)23-46(33,4)48(39,63-44)38(56)26-61-41(58)14-13-40(57)60-25-27-7-9-28(10-8-27)42(53(5)6)43(59)52-31-12-11-30-24-51-18-16-29(30)19-31/h7-12,15-20,24,33-34,36-37,39,42,55H,13-14,21-23,25-26H2,1-6H3,(H,52,59)/t33-,34-,36-,37-,39+,42?,45-,46-,47-,48+/m0/s1 UDLFKDHOQVRFSO-BNOUMRFGSA-N 511474 US11059789, Example 23::US11691950, Example 23 Tumor necrosis factor Homo sapiens 4.50 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511474&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436152 459628732 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071014 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCCc1ccc(cc1)C(CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H52FN3O9/c1-27-20-37-36-11-9-32-22-34(51)14-17-43(32,2)45(36,47)38(52)23-44(37,3)46(27,57)39(53)26-59-41(55)13-12-40(54)58-19-16-28-4-6-29(7-5-28)35(24-48)42(56)50-33-10-8-31-25-49-18-15-30(31)21-33/h4-8,10,14-15,17-18,21-22,25,27,35-38,52,57H,9,11-13,16,19-20,23-24,26,48H2,1-3H3,(H,50,56)/t27-,35?,36+,37+,38+,43+,44+,45+,46+/m1/s1 KDXGBJLMWSDKLX-SNLRXKSYSA-N 511475 US11059789, Example 26::US11691950, Example 26 Tumor necrosis factor Homo sapiens 227 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511475&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146440333 459628733 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071015 CN(C)C(C(=O)Nc1ccc2cnccc2c1)c1ccc(COC(=O)CCC(=O)OCC(=O)[C@@]23OC(C)(C)O[C@@H]2C[C@H]2[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]32C)cc1 InChI=1S/C48H54FN3O10/c1-44(2)61-39-23-36-35-14-12-32-22-34(53)17-19-45(32,3)47(35,49)37(54)24-46(36,4)48(39,62-44)38(55)27-60-41(57)16-15-40(56)59-26-28-7-9-29(10-8-28)42(52(5)6)43(58)51-33-13-11-31-25-50-20-18-30(31)21-33/h7-11,13,17-22,25,35-37,39,42,54H,12,14-16,23-24,26-27H2,1-6H3,(H,51,58)/t35-,36-,37-,39+,42?,45-,46-,47-,48+/m0/s1 NJXDFCQZYYGOBB-KNPNDIDRSA-N 511476 US11059789, Example 28::US11691950, Example 28 Tumor necrosis factor Homo sapiens 15.5 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511476&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436220 459628734 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071016 CC(C)(C)OC(=O)NC[C@@H](C(=O)Nc1ccc2cnccc2c1)c1ccc(COC(=O)CCC(=O)OCC(=O)[C@@]23OC(C)(C)O[C@@H]2C[C@H]2[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]32C)cc1 InChI=1S/C52H60FN3O12/c1-47(2,3)67-46(63)55-27-37(45(62)56-35-14-12-33-26-54-21-19-32(33)22-35)31-10-8-30(9-11-31)28-64-43(60)16-17-44(61)65-29-41(59)52-42(66-48(4,5)68-52)24-39-38-15-13-34-23-36(57)18-20-49(34,6)51(38,53)40(58)25-50(39,52)7/h8-12,14,18-23,26,37-40,42,58H,13,15-17,24-25,27-29H2,1-7H3,(H,55,63)(H,56,62)/t37-,38+,39+,40+,42-,49+,50+,51+,52-/m1/s1 OPJTYLHDVVEQCS-MWJPEANFSA-N 511477 US11059789, Example 29::US11691950, Example 29 Tumor necrosis factor Homo sapiens 71.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511477&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436163 459628735 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071017 CC(C)(C)OC(=O)NCC(C(=O)Nc1ccc2cnccc2c1)c1ccc(CCOC(=O)CCC(=O)OCC(=O)[C@@]23OC(C)(C)O[C@@H]2C[C@H]2[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]32C)cc1 InChI=1S/C53H61F2N3O12/c1-48(2,3)69-47(65)57-28-36(46(64)58-34-13-12-33-27-56-20-17-32(33)22-34)31-10-8-30(9-11-31)18-21-66-44(62)14-15-45(63)67-29-42(61)53-43(68-49(4,5)70-53)25-37-38-24-40(54)39-23-35(59)16-19-50(39,6)52(38,55)41(60)26-51(37,53)7/h8-13,16-17,19-20,22-23,27,36-38,40-41,43,60H,14-15,18,21,24-26,28-29H2,1-7H3,(H,57,65)(H,58,64)/t36?,37-,38-,40-,41-,43+,50-,51-,52-,53+/m0/s1 PLVZEHZCPBAVPV-RHEVKKQJSA-N 511478 US11059789, Example 31::US11691950, Example 31 Tumor necrosis factor Homo sapiens 5465 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511478&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146436319 459628736 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071018 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCCc1ccc(cc1)C(CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H52FN3O9/c1-26-18-38-37-11-9-31-20-33(52)12-15-44(31,2)46(37,48)39(53)22-45(38,3)47(26,58)40(54)25-60-43(57)35-21-34(35)42(56)59-17-14-27-4-6-28(7-5-27)36(23-49)41(55)51-32-10-8-30-24-50-16-13-29(30)19-32/h4-8,10,12-13,15-16,19-20,24,26,34-39,53,58H,9,11,14,17-18,21-23,25,49H2,1-3H3,(H,51,55)/t26-,34?,35?,36?,37+,38+,39+,44+,45+,46+,47+/m1/s1 CHDOSVLRPHWCQD-HRAKHHOHSA-N 511479 US11059789, Example 37::US11691950, Example 37 Tumor necrosis factor Homo sapiens 3100 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511479&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 146440439 459628737 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 2AZ5,3ALQ,3IT8,3L9J,4G3Y,4TWT,5M2I,5M2J,5M2M,5MU8,5WUX,5YOY,6OOY,6OOZ,6X81,6X82,6X83,6X85,6X86,7JRA Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 1071019 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58)/t32-,33+,34+,36+,37+,39-,44+,45+,46+,47-/m1/s1 QXQGSOMQKZFIRY-KUDXWLMMSA-N 511480 US11059789, Example 40::US11691950, Example 40 Rho-associated protein kinase 2 Homo sapiens 13.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 2F2U,2H9V,4WOT,5U7Q,6ED6,7JNT,7JOV,7P6N,8GDS Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1071020 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58)/t32-,33+,34+,36+,37+,39-,44+,45+,46+,47-/m1/s1 QXQGSOMQKZFIRY-KUDXWLMMSA-N 511480 US11059789, Example 40::US11691950, Example 40 Rho-associated protein kinase 1 Homo sapiens 19.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 1S1C,2ESM,2ETK,2ETR,2V55,3D9V,3NCZ,3NDM,3O0Z,3TV7,3TWJ,3V8S,4L2W,4W7P,4YVC,4YVE,5BML,5HVU,5KKS,5KKT,5UZJ,5WNE,5WNF,5WNG,5WNH,6E9W,6ED6,7JOU,7S25,7S26,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1071021 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58)/t32-,33+,34+,36+,37+,39-,44+,45+,46+,47-/m1/s1 QXQGSOMQKZFIRY-KUDXWLMMSA-N 511480 US11059789, Example 40::US11691950, Example 40 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 71.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 1FMO,1J3H,1JLU,1L3R,1RE8,1REJ,1REK,1XH9,2CPK,2GNF,2GNG,2GNH,2GNI,2QCS,2QVS,2UZT,2UZU,2UZV,2UZW,3AGL,3AGM,3FJQ,3IDB,3IDC,3L9L,3MVJ,3O7L,3OOG,3OVV,3OW3,3OWP,3OXT,3P0M,3POO,3TNP,3TNQ,3VQH,4DFY,4DG0,4DG2,4DG3,4DH1,4DH3,4DH5,4DH7,4DH8,4DIN,4HPT,4HPU,4IAC,4IAD,4IAF,4IAI,4IAK,4IAY,4IAZ,4IB0,4IB1,4IB3,4UJ1,4UJ2,4UJ9,4UJA,4UJB,4WB5,4WBB,4X6Q,4XW4,4XW5,4XW6,5BX6,5BX7,5IZF,5IZJ,5J5X,5JR7,5UZK,6BYS,6C0U,6E21,6NO7,6QJ7,7UJX,7V0G,7Y1G cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1071022 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58)/t32-,33+,34+,36+,37+,39-,44+,45+,46+,47-/m1/s1 QXQGSOMQKZFIRY-KUDXWLMMSA-N 511480 US11059789, Example 40::US11691950, Example 40 Tyrosine-protein kinase JAK1 Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 3EYG,3EYH,4E4L,4E4N,4E5W,4EHZ,4EI4,4FK6,4I5C,4IVB,4IVC,4IVD,4K6Z,4K77,5E1E,5HX8,5IXD,5IXI,5L04,5WO4,6AAH,6ELR,6GGH,6HZU,6N77,6N78,6N79,6N7A,6N7B,6N7C,6N7D,6RSB,6RSC,6RSD,6RSE,6RSH,6SM8,6SMB,6TPE,6TPF Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1071023 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58)/t32-,33+,34+,36+,37+,39-,44+,45+,46+,47-/m1/s1 QXQGSOMQKZFIRY-KUDXWLMMSA-N 511480 US11059789, Example 40::US11691950, Example 40 Tyrosine-protein kinase JAK2 Homo sapiens 38320 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 2B7A,3E62,3E63,3E64,3FUP,3IO7,3IOK,3JY9,3KCK,3KRR,3LPB,3Q32,3RVG,3TJC,3TJD,4AQC,4D0W,4D0X,4D1S,4HGE,4IVA,4JI9,4JIA,4P7E,4YTC,4YTF,4YTH,4YTI,4ZIM,5AEP,5CF4,5CF5,5CF6,5CF8,5USY,6DRW,6E2P,6E2Q,6VGL,6VN8,6VNB,6VNC,6VNE,6VNF,6VNG,6VNH,6VNI,6VNJ,6VNK,6VNL,6VNM,6VS3,6VSN,6WTN,6WTO,6WTP,6WTQ,7F7W,7LL4,7LL5,7REE,7UYW Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1071024 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58)/t32-,33+,34+,36+,37+,39-,44+,45+,46+,47-/m1/s1 QXQGSOMQKZFIRY-KUDXWLMMSA-N 511480 US11059789, Example 40::US11691950, Example 40 Tyrosine-protein kinase JAK3 Homo sapiens 17730 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 3PJC,5TOZ,5TTS,5TTU,5TTV,6DA4,6DB3,6DB4,6DUD,7C3N Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 1071025 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58)/t32-,33+,34+,36+,37+,39-,44+,45+,46+,47-/m1/s1 QXQGSOMQKZFIRY-KUDXWLMMSA-N 511480 US11059789, Example 40::US11691950, Example 40 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 3NZ0,3ZON,4PO6,4PY1,5C01,5C03,6DBK,6DBM,6VNS,6VNV,6VNX,6VNY,6X8F,6X8G,7AX4,7UYR,7UYS,7UYT,7UYU,8S98,8S99,8S9A Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1071026 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58)/t32-,33+,34+,36+,37+,39-,44+,45+,46+,47-/m1/s1 QXQGSOMQKZFIRY-KUDXWLMMSA-N 511480 US11059789, Example 40::US11691950, Example 40 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 32886 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1071027 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55)/t26-,34-,35+,36+,37+,42+,43+,44+,45+/m1/s1 LYJKMVFAIXOQLE-KFTDLJQOSA-N 511481 US11059789, Example 25::US11691950, Example 25 Rho-associated protein kinase 2 Homo sapiens 17.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 2F2U,2H9V,4WOT,5U7Q,6ED6,7JNT,7JOV,7P6N,8GDS Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1071028 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55)/t26-,34-,35+,36+,37+,42+,43+,44+,45+/m1/s1 LYJKMVFAIXOQLE-KFTDLJQOSA-N 511481 US11059789, Example 25::US11691950, Example 25 Rho-associated protein kinase 1 Homo sapiens 25.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 1S1C,2ESM,2ETK,2ETR,2V55,3D9V,3NCZ,3NDM,3O0Z,3TV7,3TWJ,3V8S,4L2W,4W7P,4YVC,4YVE,5BML,5HVU,5KKS,5KKT,5UZJ,5WNE,5WNF,5WNG,5WNH,6E9W,6ED6,7JOU,7S25,7S26,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1071029 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55)/t26-,34-,35+,36+,37+,42+,43+,44+,45+/m1/s1 LYJKMVFAIXOQLE-KFTDLJQOSA-N 511481 US11059789, Example 25::US11691950, Example 25 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 138 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 1FMO,1J3H,1JLU,1L3R,1RE8,1REJ,1REK,1XH9,2CPK,2GNF,2GNG,2GNH,2GNI,2QCS,2QVS,2UZT,2UZU,2UZV,2UZW,3AGL,3AGM,3FJQ,3IDB,3IDC,3L9L,3MVJ,3O7L,3OOG,3OVV,3OW3,3OWP,3OXT,3P0M,3POO,3TNP,3TNQ,3VQH,4DFY,4DG0,4DG2,4DG3,4DH1,4DH3,4DH5,4DH7,4DH8,4DIN,4HPT,4HPU,4IAC,4IAD,4IAF,4IAI,4IAK,4IAY,4IAZ,4IB0,4IB1,4IB3,4UJ1,4UJ2,4UJ9,4UJA,4UJB,4WB5,4WBB,4X6Q,4XW4,4XW5,4XW6,5BX6,5BX7,5IZF,5IZJ,5J5X,5JR7,5UZK,6BYS,6C0U,6E21,6NO7,6QJ7,7UJX,7V0G,7Y1G cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1071030 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55)/t26-,34-,35+,36+,37+,42+,43+,44+,45+/m1/s1 LYJKMVFAIXOQLE-KFTDLJQOSA-N 511481 US11059789, Example 25::US11691950, Example 25 Tyrosine-protein kinase JAK1 Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 3EYG,3EYH,4E4L,4E4N,4E5W,4EHZ,4EI4,4FK6,4I5C,4IVB,4IVC,4IVD,4K6Z,4K77,5E1E,5HX8,5IXD,5IXI,5L04,5WO4,6AAH,6ELR,6GGH,6HZU,6N77,6N78,6N79,6N7A,6N7B,6N7C,6N7D,6RSB,6RSC,6RSD,6RSE,6RSH,6SM8,6SMB,6TPE,6TPF Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1071031 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55)/t26-,34-,35+,36+,37+,42+,43+,44+,45+/m1/s1 LYJKMVFAIXOQLE-KFTDLJQOSA-N 511481 US11059789, Example 25::US11691950, Example 25 Tyrosine-protein kinase JAK2 Homo sapiens 40871 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 2B7A,3E62,3E63,3E64,3FUP,3IO7,3IOK,3JY9,3KCK,3KRR,3LPB,3Q32,3RVG,3TJC,3TJD,4AQC,4D0W,4D0X,4D1S,4HGE,4IVA,4JI9,4JIA,4P7E,4YTC,4YTF,4YTH,4YTI,4ZIM,5AEP,5CF4,5CF5,5CF6,5CF8,5USY,6DRW,6E2P,6E2Q,6VGL,6VN8,6VNB,6VNC,6VNE,6VNF,6VNG,6VNH,6VNI,6VNJ,6VNK,6VNL,6VNM,6VS3,6VSN,6WTN,6WTO,6WTP,6WTQ,7F7W,7LL4,7LL5,7REE,7UYW Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1071032 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55)/t26-,34-,35+,36+,37+,42+,43+,44+,45+/m1/s1 LYJKMVFAIXOQLE-KFTDLJQOSA-N 511481 US11059789, Example 25::US11691950, Example 25 Tyrosine-protein kinase JAK3 Homo sapiens 21390 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 3PJC,5TOZ,5TTS,5TTU,5TTV,6DA4,6DB3,6DB4,6DUD,7C3N Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 1071033 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55)/t26-,34-,35+,36+,37+,42+,43+,44+,45+/m1/s1 LYJKMVFAIXOQLE-KFTDLJQOSA-N 511481 US11059789, Example 25::US11691950, Example 25 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 3NZ0,3ZON,4PO6,4PY1,5C01,5C03,6DBK,6DBM,6VNS,6VNV,6VNX,6VNY,6X8F,6X8G,7AX4,7UYR,7UYS,7UYT,7UYU,8S98,8S99,8S9A Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1071034 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55)/t26-,34-,35+,36+,37+,42+,43+,44+,45+/m1/s1 LYJKMVFAIXOQLE-KFTDLJQOSA-N 511481 US11059789, Example 25::US11691950, Example 25 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 38496 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1071035 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55)/t25-,33-,34+,35+,36+,37+,42+,43+,44+,45+/m1/s1 NKWSAYGUIMPROA-PNSJQOAOSA-N 511482 US11059789, Example 83::US11691950, Example 83 Rho-associated protein kinase 2 Homo sapiens 9.00 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 2F2U,2H9V,4WOT,5U7Q,6ED6,7JNT,7JOV,7P6N,8GDS Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1071036 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55)/t25-,33-,34+,35+,36+,37+,42+,43+,44+,45+/m1/s1 NKWSAYGUIMPROA-PNSJQOAOSA-N 511482 US11059789, Example 83::US11691950, Example 83 Rho-associated protein kinase 1 Homo sapiens 11.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 1S1C,2ESM,2ETK,2ETR,2V55,3D9V,3NCZ,3NDM,3O0Z,3TV7,3TWJ,3V8S,4L2W,4W7P,4YVC,4YVE,5BML,5HVU,5KKS,5KKT,5UZJ,5WNE,5WNF,5WNG,5WNH,6E9W,6ED6,7JOU,7S25,7S26,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1071037 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55)/t25-,33-,34+,35+,36+,37+,42+,43+,44+,45+/m1/s1 NKWSAYGUIMPROA-PNSJQOAOSA-N 511482 US11059789, Example 83::US11691950, Example 83 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 29.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 1FMO,1J3H,1JLU,1L3R,1RE8,1REJ,1REK,1XH9,2CPK,2GNF,2GNG,2GNH,2GNI,2QCS,2QVS,2UZT,2UZU,2UZV,2UZW,3AGL,3AGM,3FJQ,3IDB,3IDC,3L9L,3MVJ,3O7L,3OOG,3OVV,3OW3,3OWP,3OXT,3P0M,3POO,3TNP,3TNQ,3VQH,4DFY,4DG0,4DG2,4DG3,4DH1,4DH3,4DH5,4DH7,4DH8,4DIN,4HPT,4HPU,4IAC,4IAD,4IAF,4IAI,4IAK,4IAY,4IAZ,4IB0,4IB1,4IB3,4UJ1,4UJ2,4UJ9,4UJA,4UJB,4WB5,4WBB,4X6Q,4XW4,4XW5,4XW6,5BX6,5BX7,5IZF,5IZJ,5J5X,5JR7,5UZK,6BYS,6C0U,6E21,6NO7,6QJ7,7UJX,7V0G,7Y1G cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1071038 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55)/t25-,33-,34+,35+,36+,37+,42+,43+,44+,45+/m1/s1 NKWSAYGUIMPROA-PNSJQOAOSA-N 511482 US11059789, Example 83::US11691950, Example 83 Tyrosine-protein kinase JAK1 Homo sapiens 34675 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 3EYG,3EYH,4E4L,4E4N,4E5W,4EHZ,4EI4,4FK6,4I5C,4IVB,4IVC,4IVD,4K6Z,4K77,5E1E,5HX8,5IXD,5IXI,5L04,5WO4,6AAH,6ELR,6GGH,6HZU,6N77,6N78,6N79,6N7A,6N7B,6N7C,6N7D,6RSB,6RSC,6RSD,6RSE,6RSH,6SM8,6SMB,6TPE,6TPF Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1071039 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55)/t25-,33-,34+,35+,36+,37+,42+,43+,44+,45+/m1/s1 NKWSAYGUIMPROA-PNSJQOAOSA-N 511482 US11059789, Example 83::US11691950, Example 83 Tyrosine-protein kinase JAK2 Homo sapiens 22021 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 2B7A,3E62,3E63,3E64,3FUP,3IO7,3IOK,3JY9,3KCK,3KRR,3LPB,3Q32,3RVG,3TJC,3TJD,4AQC,4D0W,4D0X,4D1S,4HGE,4IVA,4JI9,4JIA,4P7E,4YTC,4YTF,4YTH,4YTI,4ZIM,5AEP,5CF4,5CF5,5CF6,5CF8,5USY,6DRW,6E2P,6E2Q,6VGL,6VN8,6VNB,6VNC,6VNE,6VNF,6VNG,6VNH,6VNI,6VNJ,6VNK,6VNL,6VNM,6VS3,6VSN,6WTN,6WTO,6WTP,6WTQ,7F7W,7LL4,7LL5,7REE,7UYW Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1071040 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55)/t25-,33-,34+,35+,36+,37+,42+,43+,44+,45+/m1/s1 NKWSAYGUIMPROA-PNSJQOAOSA-N 511482 US11059789, Example 83::US11691950, Example 83 Tyrosine-protein kinase JAK3 Homo sapiens 7729 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 3PJC,5TOZ,5TTS,5TTU,5TTV,6DA4,6DB3,6DB4,6DUD,7C3N Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 1071041 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55)/t25-,33-,34+,35+,36+,37+,42+,43+,44+,45+/m1/s1 NKWSAYGUIMPROA-PNSJQOAOSA-N 511482 US11059789, Example 83::US11691950, Example 83 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 3NZ0,3ZON,4PO6,4PY1,5C01,5C03,6DBK,6DBM,6VNS,6VNV,6VNX,6VNY,6X8F,6X8G,7AX4,7UYR,7UYS,7UYT,7UYU,8S98,8S99,8S9A Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1071042 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55)/t25-,33-,34+,35+,36+,37+,42+,43+,44+,45+/m1/s1 NKWSAYGUIMPROA-PNSJQOAOSA-N 511482 US11059789, Example 83::US11691950, Example 83 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 19151 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1071043 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57)/t28-,38-,39+,40+,41+,46+,47+,48+,49+/m1/s1 BJLOBSMGZUMYOP-WDNLRGLVSA-N 511483 US11059789, Example 66::US11691950, Example 66 Rho-associated protein kinase 2 Homo sapiens 26.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 2F2U,2H9V,4WOT,5U7Q,6ED6,7JNT,7JOV,7P6N,8GDS Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1071044 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57)/t28-,38-,39+,40+,41+,46+,47+,48+,49+/m1/s1 BJLOBSMGZUMYOP-WDNLRGLVSA-N 511483 US11059789, Example 66::US11691950, Example 66 Rho-associated protein kinase 1 Homo sapiens 36.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 1S1C,2ESM,2ETK,2ETR,2V55,3D9V,3NCZ,3NDM,3O0Z,3TV7,3TWJ,3V8S,4L2W,4W7P,4YVC,4YVE,5BML,5HVU,5KKS,5KKT,5UZJ,5WNE,5WNF,5WNG,5WNH,6E9W,6ED6,7JOU,7S25,7S26,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1071045 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57)/t28-,38-,39+,40+,41+,46+,47+,48+,49+/m1/s1 BJLOBSMGZUMYOP-WDNLRGLVSA-N 511483 US11059789, Example 66::US11691950, Example 66 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 117 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 1FMO,1J3H,1JLU,1L3R,1RE8,1REJ,1REK,1XH9,2CPK,2GNF,2GNG,2GNH,2GNI,2QCS,2QVS,2UZT,2UZU,2UZV,2UZW,3AGL,3AGM,3FJQ,3IDB,3IDC,3L9L,3MVJ,3O7L,3OOG,3OVV,3OW3,3OWP,3OXT,3P0M,3POO,3TNP,3TNQ,3VQH,4DFY,4DG0,4DG2,4DG3,4DH1,4DH3,4DH5,4DH7,4DH8,4DIN,4HPT,4HPU,4IAC,4IAD,4IAF,4IAI,4IAK,4IAY,4IAZ,4IB0,4IB1,4IB3,4UJ1,4UJ2,4UJ9,4UJA,4UJB,4WB5,4WBB,4X6Q,4XW4,4XW5,4XW6,5BX6,5BX7,5IZF,5IZJ,5J5X,5JR7,5UZK,6BYS,6C0U,6E21,6NO7,6QJ7,7UJX,7V0G,7Y1G cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1071046 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57)/t28-,38-,39+,40+,41+,46+,47+,48+,49+/m1/s1 BJLOBSMGZUMYOP-WDNLRGLVSA-N 511483 US11059789, Example 66::US11691950, Example 66 Tyrosine-protein kinase JAK1 Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 3EYG,3EYH,4E4L,4E4N,4E5W,4EHZ,4EI4,4FK6,4I5C,4IVB,4IVC,4IVD,4K6Z,4K77,5E1E,5HX8,5IXD,5IXI,5L04,5WO4,6AAH,6ELR,6GGH,6HZU,6N77,6N78,6N79,6N7A,6N7B,6N7C,6N7D,6RSB,6RSC,6RSD,6RSE,6RSH,6SM8,6SMB,6TPE,6TPF Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1071047 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57)/t28-,38-,39+,40+,41+,46+,47+,48+,49+/m1/s1 BJLOBSMGZUMYOP-WDNLRGLVSA-N 511483 US11059789, Example 66::US11691950, Example 66 Tyrosine-protein kinase JAK2 Homo sapiens 36241 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 2B7A,3E62,3E63,3E64,3FUP,3IO7,3IOK,3JY9,3KCK,3KRR,3LPB,3Q32,3RVG,3TJC,3TJD,4AQC,4D0W,4D0X,4D1S,4HGE,4IVA,4JI9,4JIA,4P7E,4YTC,4YTF,4YTH,4YTI,4ZIM,5AEP,5CF4,5CF5,5CF6,5CF8,5USY,6DRW,6E2P,6E2Q,6VGL,6VN8,6VNB,6VNC,6VNE,6VNF,6VNG,6VNH,6VNI,6VNJ,6VNK,6VNL,6VNM,6VS3,6VSN,6WTN,6WTO,6WTP,6WTQ,7F7W,7LL4,7LL5,7REE,7UYW Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1071048 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57)/t28-,38-,39+,40+,41+,46+,47+,48+,49+/m1/s1 BJLOBSMGZUMYOP-WDNLRGLVSA-N 511483 US11059789, Example 66::US11691950, Example 66 Tyrosine-protein kinase JAK3 Homo sapiens 43246 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 3PJC,5TOZ,5TTS,5TTU,5TTV,6DA4,6DB3,6DB4,6DUD,7C3N Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 1071049 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57)/t28-,38-,39+,40+,41+,46+,47+,48+,49+/m1/s1 BJLOBSMGZUMYOP-WDNLRGLVSA-N 511483 US11059789, Example 66::US11691950, Example 66 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 3NZ0,3ZON,4PO6,4PY1,5C01,5C03,6DBK,6DBM,6VNS,6VNV,6VNX,6VNY,6X8F,6X8G,7AX4,7UYR,7UYS,7UYT,7UYU,8S98,8S99,8S9A Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1071050 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57)/t28-,38-,39+,40+,41+,46+,47+,48+,49+/m1/s1 BJLOBSMGZUMYOP-WDNLRGLVSA-N 511483 US11059789, Example 66::US11691950, Example 66 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1071051 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57)/t34-,35+,36+,37+,39-,44+,45+,46+,47-/m1/s1 SDZRYLPROGBZMB-UPVGTXGNSA-N 511484 US11059789, Example 33::US11691950, Example 33 Rho-associated protein kinase 2 Homo sapiens 14.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 2F2U,2H9V,4WOT,5U7Q,6ED6,7JNT,7JOV,7P6N,8GDS Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1071052 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57)/t34-,35+,36+,37+,39-,44+,45+,46+,47-/m1/s1 SDZRYLPROGBZMB-UPVGTXGNSA-N 511484 US11059789, Example 33::US11691950, Example 33 Rho-associated protein kinase 1 Homo sapiens 21.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 1S1C,2ESM,2ETK,2ETR,2V55,3D9V,3NCZ,3NDM,3O0Z,3TV7,3TWJ,3V8S,4L2W,4W7P,4YVC,4YVE,5BML,5HVU,5KKS,5KKT,5UZJ,5WNE,5WNF,5WNG,5WNH,6E9W,6ED6,7JOU,7S25,7S26,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1071053 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57)/t34-,35+,36+,37+,39-,44+,45+,46+,47-/m1/s1 SDZRYLPROGBZMB-UPVGTXGNSA-N 511484 US11059789, Example 33::US11691950, Example 33 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 81.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 1FMO,1J3H,1JLU,1L3R,1RE8,1REJ,1REK,1XH9,2CPK,2GNF,2GNG,2GNH,2GNI,2QCS,2QVS,2UZT,2UZU,2UZV,2UZW,3AGL,3AGM,3FJQ,3IDB,3IDC,3L9L,3MVJ,3O7L,3OOG,3OVV,3OW3,3OWP,3OXT,3P0M,3POO,3TNP,3TNQ,3VQH,4DFY,4DG0,4DG2,4DG3,4DH1,4DH3,4DH5,4DH7,4DH8,4DIN,4HPT,4HPU,4IAC,4IAD,4IAF,4IAI,4IAK,4IAY,4IAZ,4IB0,4IB1,4IB3,4UJ1,4UJ2,4UJ9,4UJA,4UJB,4WB5,4WBB,4X6Q,4XW4,4XW5,4XW6,5BX6,5BX7,5IZF,5IZJ,5J5X,5JR7,5UZK,6BYS,6C0U,6E21,6NO7,6QJ7,7UJX,7V0G,7Y1G cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1071054 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57)/t34-,35+,36+,37+,39-,44+,45+,46+,47-/m1/s1 SDZRYLPROGBZMB-UPVGTXGNSA-N 511484 US11059789, Example 33::US11691950, Example 33 Tyrosine-protein kinase JAK1 Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 3EYG,3EYH,4E4L,4E4N,4E5W,4EHZ,4EI4,4FK6,4I5C,4IVB,4IVC,4IVD,4K6Z,4K77,5E1E,5HX8,5IXD,5IXI,5L04,5WO4,6AAH,6ELR,6GGH,6HZU,6N77,6N78,6N79,6N7A,6N7B,6N7C,6N7D,6RSB,6RSC,6RSD,6RSE,6RSH,6SM8,6SMB,6TPE,6TPF Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1071055 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57)/t34-,35+,36+,37+,39-,44+,45+,46+,47-/m1/s1 SDZRYLPROGBZMB-UPVGTXGNSA-N 511484 US11059789, Example 33::US11691950, Example 33 Tyrosine-protein kinase JAK2 Homo sapiens 42354 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 2B7A,3E62,3E63,3E64,3FUP,3IO7,3IOK,3JY9,3KCK,3KRR,3LPB,3Q32,3RVG,3TJC,3TJD,4AQC,4D0W,4D0X,4D1S,4HGE,4IVA,4JI9,4JIA,4P7E,4YTC,4YTF,4YTH,4YTI,4ZIM,5AEP,5CF4,5CF5,5CF6,5CF8,5USY,6DRW,6E2P,6E2Q,6VGL,6VN8,6VNB,6VNC,6VNE,6VNF,6VNG,6VNH,6VNI,6VNJ,6VNK,6VNL,6VNM,6VS3,6VSN,6WTN,6WTO,6WTP,6WTQ,7F7W,7LL4,7LL5,7REE,7UYW Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1071056 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57)/t34-,35+,36+,37+,39-,44+,45+,46+,47-/m1/s1 SDZRYLPROGBZMB-UPVGTXGNSA-N 511484 US11059789, Example 33::US11691950, Example 33 Tyrosine-protein kinase JAK3 Homo sapiens 30082 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 3PJC,5TOZ,5TTS,5TTU,5TTV,6DA4,6DB3,6DB4,6DUD,7C3N Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 1071057 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57)/t34-,35+,36+,37+,39-,44+,45+,46+,47-/m1/s1 SDZRYLPROGBZMB-UPVGTXGNSA-N 511484 US11059789, Example 33::US11691950, Example 33 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 3NZ0,3ZON,4PO6,4PY1,5C01,5C03,6DBK,6DBM,6VNS,6VNV,6VNX,6VNY,6X8F,6X8G,7AX4,7UYR,7UYS,7UYT,7UYU,8S98,8S99,8S9A Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1071058 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57)/t34-,35+,36+,37+,39-,44+,45+,46+,47-/m1/s1 SDZRYLPROGBZMB-UPVGTXGNSA-N 511484 US11059789, Example 33::US11691950, Example 33 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 40091 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1071059 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54)/t25-,33?,34?,35-,36+,37+,38+,43+,44+,45+,46+/m1/s1 NZTPJNIILSLMRH-XGTQYUGGSA-N 511485 US11059789, Example 27::US11691950, Example 27 Rho-associated protein kinase 2 Homo sapiens 13.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 2F2U,2H9V,4WOT,5U7Q,6ED6,7JNT,7JOV,7P6N,8GDS Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1071060 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54)/t25-,33?,34?,35-,36+,37+,38+,43+,44+,45+,46+/m1/s1 NZTPJNIILSLMRH-XGTQYUGGSA-N 511485 US11059789, Example 27::US11691950, Example 27 Rho-associated protein kinase 1 Homo sapiens 29.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 1S1C,2ESM,2ETK,2ETR,2V55,3D9V,3NCZ,3NDM,3O0Z,3TV7,3TWJ,3V8S,4L2W,4W7P,4YVC,4YVE,5BML,5HVU,5KKS,5KKT,5UZJ,5WNE,5WNF,5WNG,5WNH,6E9W,6ED6,7JOU,7S25,7S26,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1071061 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54)/t25-,33?,34?,35-,36+,37+,38+,43+,44+,45+,46+/m1/s1 NZTPJNIILSLMRH-XGTQYUGGSA-N 511485 US11059789, Example 27::US11691950, Example 27 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 317 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 1FMO,1J3H,1JLU,1L3R,1RE8,1REJ,1REK,1XH9,2CPK,2GNF,2GNG,2GNH,2GNI,2QCS,2QVS,2UZT,2UZU,2UZV,2UZW,3AGL,3AGM,3FJQ,3IDB,3IDC,3L9L,3MVJ,3O7L,3OOG,3OVV,3OW3,3OWP,3OXT,3P0M,3POO,3TNP,3TNQ,3VQH,4DFY,4DG0,4DG2,4DG3,4DH1,4DH3,4DH5,4DH7,4DH8,4DIN,4HPT,4HPU,4IAC,4IAD,4IAF,4IAI,4IAK,4IAY,4IAZ,4IB0,4IB1,4IB3,4UJ1,4UJ2,4UJ9,4UJA,4UJB,4WB5,4WBB,4X6Q,4XW4,4XW5,4XW6,5BX6,5BX7,5IZF,5IZJ,5J5X,5JR7,5UZK,6BYS,6C0U,6E21,6NO7,6QJ7,7UJX,7V0G,7Y1G cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1071062 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54)/t25-,33?,34?,35-,36+,37+,38+,43+,44+,45+,46+/m1/s1 NZTPJNIILSLMRH-XGTQYUGGSA-N 511485 US11059789, Example 27::US11691950, Example 27 Tyrosine-protein kinase JAK1 Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 3EYG,3EYH,4E4L,4E4N,4E5W,4EHZ,4EI4,4FK6,4I5C,4IVB,4IVC,4IVD,4K6Z,4K77,5E1E,5HX8,5IXD,5IXI,5L04,5WO4,6AAH,6ELR,6GGH,6HZU,6N77,6N78,6N79,6N7A,6N7B,6N7C,6N7D,6RSB,6RSC,6RSD,6RSE,6RSH,6SM8,6SMB,6TPE,6TPF Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1071063 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54)/t25-,33?,34?,35-,36+,37+,38+,43+,44+,45+,46+/m1/s1 NZTPJNIILSLMRH-XGTQYUGGSA-N 511485 US11059789, Example 27::US11691950, Example 27 Tyrosine-protein kinase JAK2 Homo sapiens 41673 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 2B7A,3E62,3E63,3E64,3FUP,3IO7,3IOK,3JY9,3KCK,3KRR,3LPB,3Q32,3RVG,3TJC,3TJD,4AQC,4D0W,4D0X,4D1S,4HGE,4IVA,4JI9,4JIA,4P7E,4YTC,4YTF,4YTH,4YTI,4ZIM,5AEP,5CF4,5CF5,5CF6,5CF8,5USY,6DRW,6E2P,6E2Q,6VGL,6VN8,6VNB,6VNC,6VNE,6VNF,6VNG,6VNH,6VNI,6VNJ,6VNK,6VNL,6VNM,6VS3,6VSN,6WTN,6WTO,6WTP,6WTQ,7F7W,7LL4,7LL5,7REE,7UYW Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1071064 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54)/t25-,33?,34?,35-,36+,37+,38+,43+,44+,45+,46+/m1/s1 NZTPJNIILSLMRH-XGTQYUGGSA-N 511485 US11059789, Example 27::US11691950, Example 27 Tyrosine-protein kinase JAK3 Homo sapiens 11632 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 3PJC,5TOZ,5TTS,5TTU,5TTV,6DA4,6DB3,6DB4,6DUD,7C3N Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 1071065 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54)/t25-,33?,34?,35-,36+,37+,38+,43+,44+,45+,46+/m1/s1 NZTPJNIILSLMRH-XGTQYUGGSA-N 511485 US11059789, Example 27::US11691950, Example 27 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 3NZ0,3ZON,4PO6,4PY1,5C01,5C03,6DBK,6DBM,6VNS,6VNV,6VNX,6VNY,6X8F,6X8G,7AX4,7UYR,7UYS,7UYT,7UYU,8S98,8S99,8S9A Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1071066 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54)/t25-,33?,34?,35-,36+,37+,38+,43+,44+,45+,46+/m1/s1 NZTPJNIILSLMRH-XGTQYUGGSA-N 511485 US11059789, Example 27::US11691950, Example 27 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 46807 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1071067 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52)/t32-,33?,34?,35+,36-,37-,39+,43-,44-,45-/m0/s1 HSRYETVWRVWJQQ-RTDIISPTSA-N 511486 US11059789, Example 19::US11691950, Example 19 Rho-associated protein kinase 2 Homo sapiens 27.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5478&target=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Rho-associated+protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MSRPPPTGKMPGAPETAPGDGAGASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYRENLLLSDSPSCRETDSIQSRKNEESQEIQKKLYTLEEHLSNEMQAKEELEQKCKSVNTRLEKTAKELEEEITLRKSVESALRQLEREKALLQHKNAEYQRKADHEADKKRNLENDVNSLKDQLEDLKKRNQNSQISTEKVNQLQRQLDETNALLRTESDTAARLRKTQAESSKQIQQLESNNRDLQDKNCLLETAKLKLEKEFINLQSALESERRDRTHGSEIINDLQGRICGLEEDLKNGKILLAKVELEKRQLQERFTDLEKEKSNMEIDMTYQLKVIQQSLEQEEAEHKATKARLADKNKIYESIEEAKSEAMKEMEKKLLEERTLKQKVENLLLEAEKRCSLLDCDLKQSQQKINELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQLKQENNHLMEMKMNLEKQNAELRKERQDADGQMKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLGKELQQKKQELQDERDSLAAQLEITLTKADSEQLARSIAEEQYSDLEKEKIMKELEIKEMMARHKQELTEKDATIASLEETNRTLTSDVANLANEKEELNNKLKDVQEQLSRLKDEEISAAAIKAQFEKQLLTERTLKTQAVNKLAEIMNRKEPVKRGNDTDVRRKEKENRKLHMELKSEREKLTQQMIKYQKELNEMQAQIAEESQIRIELQMTLDSKDSDIEQLRSQLQALHIGLDSSSIGSGPGDAEADDGFPESRLEGWLSLPVRNNTKKFGWVKKYVIVSSKKILFYDSEQDKEQSNPYMVLDIDKLFHVRPVTQTDVYRADAKEIPRIFQILYANEGESKKEQEFPVEPVGEKSNYICHKGHEFIPTLYHFPTNCEACMKPLWHMFKPPPALECRRCHIKCHKDHMDKKEEIIAPCKVYYDISTAKNLLLLANSTEEQQKWVSRLVKKIPKKPPAPDPFARSSPRTSMKIQQNQSIRRPSRQLAPNKPS 2F2U,2H9V,4WOT,5U7Q,6ED6,7JNT,7JOV,7P6N,8GDS Rho-associated protein kinase 2 ROCK2_HUMAN O75116 Q53QZ0 Q53SJ7 Q9UQN5 1071068 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52)/t32-,33?,34?,35+,36-,37-,39+,43-,44-,45-/m0/s1 HSRYETVWRVWJQQ-RTDIISPTSA-N 511486 US11059789, Example 19::US11691950, Example 19 Rho-associated protein kinase 1 Homo sapiens 58.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2734&target=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Rho-associated+protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNRTSSNADKSLQESLQKTIYKLEEQLHNEMQLKDEMEQKCRTSNIKLDKIMKELDEEGNQRRNLESTVSQIEKEKMLLQHRINEYQRKAEQENEKRRNVENEVSTLKDQLEDLKKVSQNSQLANEKLSQLQKQLEEANDLLRTESDTAVRLRKSHTEMSKSISQLESLNRELQERNRILENSKSQTDKDYYQLQAILEAERRDRGHDSEMIGDLQARITSLQEEVKHLKHNLEKVEGERKEAQDMLNHSEKEKNNLEIDLNYKLKSLQQRLEQEVNEHKVTKARLTDKHQSIEEAKSVAMCEMEKKLKEEREAREKAENRVVQIEKQCSMLDVDLKQSQQKLEHLTGNKERMEDEVKNLTLQLEQESNKRLLLQNELKTQAFEADNLKGLEKQMKQEINTLLEAKRLLEFELAQLTKQYRGNEGQMRELQDQLEAEQYFSTLYKTQVKELKEEIEEKNRENLKKIQELQNEKETLATQLDLAETKAESEQLARGLLEEQYFELTQESKKAASRNRQEITDKDHTVSRLEEANSMLTKDIEILRRENEELTEKMKKAEEEYKLEKEEEISNLKAAFEKNINTERTLKTQAVNKLAEIMNRKDFKIDRKKANTQDLRKKEKENRKLQLELNQEREKFNQMVVKHQKELNDMQAQLVEECAHRNELQMQLASKESDIEQLRAKLLDLSDSTSVASFPSADETDGNLPESRIEGWLSVPNRGNIKRYGWKKQYVVVSSKKILFYNDEQDKEQSNPSMVLDIDKLFHVRPVTQGDVYRAETEEIPKIFQILYANEGECRKDVEMEPVQQAEKTNFQNHKGHEFIPTLYHFPANCDACAKPLWHVFKPPPALECRRCHVKCHRDHLDKKEDLICPCKVSYDVTSARDMLLLACSQDEQKKWVTHLVKKIPKNPPSGFVRASPRTLSTRSTANQSFRKVVKNTSGKTS 1S1C,2ESM,2ETK,2ETR,2V55,3D9V,3NCZ,3NDM,3O0Z,3TV7,3TWJ,3V8S,4L2W,4W7P,4YVC,4YVE,5BML,5HVU,5KKS,5KKT,5UZJ,5WNE,5WNF,5WNG,5WNH,6E9W,6ED6,7JOU,7S25,7S26,8P0S Rho-associated protein kinase 1 ROCK1_HUMAN Q13464 B0YJ91 Q2KHM4 Q59GZ4 1071069 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52)/t32-,33?,34?,35+,36-,37-,39+,43-,44-,45-/m0/s1 HSRYETVWRVWJQQ-RTDIISPTSA-N 511486 US11059789, Example 19::US11691950, Example 19 cAMP-dependent protein kinase catalytic subunit alpha Homo sapiens 332 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1592&target=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=cAMP-dependent+protein+kinase+catalytic+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF 1FMO,1J3H,1JLU,1L3R,1RE8,1REJ,1REK,1XH9,2CPK,2GNF,2GNG,2GNH,2GNI,2QCS,2QVS,2UZT,2UZU,2UZV,2UZW,3AGL,3AGM,3FJQ,3IDB,3IDC,3L9L,3MVJ,3O7L,3OOG,3OVV,3OW3,3OWP,3OXT,3P0M,3POO,3TNP,3TNQ,3VQH,4DFY,4DG0,4DG2,4DG3,4DH1,4DH3,4DH5,4DH7,4DH8,4DIN,4HPT,4HPU,4IAC,4IAD,4IAF,4IAI,4IAK,4IAY,4IAZ,4IB0,4IB1,4IB3,4UJ1,4UJ2,4UJ9,4UJA,4UJB,4WB5,4WBB,4X6Q,4XW4,4XW5,4XW6,5BX6,5BX7,5IZF,5IZJ,5J5X,5JR7,5UZK,6BYS,6C0U,6E21,6NO7,6QJ7,7UJX,7V0G,7Y1G cAMP-dependent protein kinase catalytic subunit alpha KAPCA_HUMAN P17612 Q32P54 Q9H2Y0 Q9NRB4 Q9NRH9 1071070 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52)/t32-,33?,34?,35+,36-,37-,39+,43-,44-,45-/m0/s1 HSRYETVWRVWJQQ-RTDIISPTSA-N 511486 US11059789, Example 19::US11691950, Example 19 Tyrosine-protein kinase JAK1 Homo sapiens 9574 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4917&target=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Tyrosine-protein+kinase+JAK1&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 3EYG,3EYH,4E4L,4E4N,4E5W,4EHZ,4EI4,4FK6,4I5C,4IVB,4IVC,4IVD,4K6Z,4K77,5E1E,5HX8,5IXD,5IXI,5L04,5WO4,6AAH,6ELR,6GGH,6HZU,6N77,6N78,6N79,6N7A,6N7B,6N7C,6N7D,6RSB,6RSC,6RSD,6RSE,6RSH,6SM8,6SMB,6TPE,6TPF Tyrosine-protein kinase JAK1 JAK1_HUMAN P23458 Q59GQ2 Q9UD26 1071071 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52)/t32-,33?,34?,35+,36-,37-,39+,43-,44-,45-/m0/s1 HSRYETVWRVWJQQ-RTDIISPTSA-N 511486 US11059789, Example 19::US11691950, Example 19 Tyrosine-protein kinase JAK2 Homo sapiens 13799 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4918&target=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Tyrosine-protein+kinase+JAK2&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 2B7A,3E62,3E63,3E64,3FUP,3IO7,3IOK,3JY9,3KCK,3KRR,3LPB,3Q32,3RVG,3TJC,3TJD,4AQC,4D0W,4D0X,4D1S,4HGE,4IVA,4JI9,4JIA,4P7E,4YTC,4YTF,4YTH,4YTI,4ZIM,5AEP,5CF4,5CF5,5CF6,5CF8,5USY,6DRW,6E2P,6E2Q,6VGL,6VN8,6VNB,6VNC,6VNE,6VNF,6VNG,6VNH,6VNI,6VNJ,6VNK,6VNL,6VNM,6VS3,6VSN,6WTN,6WTO,6WTP,6WTQ,7F7W,7LL4,7LL5,7REE,7UYW Tyrosine-protein kinase JAK2 JAK2_HUMAN O60674 O14636 O75297 1071072 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52)/t32-,33?,34?,35+,36-,37-,39+,43-,44-,45-/m0/s1 HSRYETVWRVWJQQ-RTDIISPTSA-N 511486 US11059789, Example 19::US11691950, Example 19 Tyrosine-protein kinase JAK3 Homo sapiens 2573 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4919&target=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Tyrosine-protein+kinase+JAK3&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSCWFPPSHIFSVEDASTQVLLYRIRFYFPNWFGLEKCHRFGLRKDLASAILDLPVLEHLFAQHRSDLVSGRLPVGLSLKEQGECLSLAVLDLARMAREQAQRPGELLKTVSYKACLPPSLRDLIQGLSFVTRRRIRRTVRRALRRVAACQADRHSLMAKYIMDLERLDPAGAAETFHVGLPGALGGHDGLGLLRVAGDGGIAWTQGEQEVLQPFCDFPEIVDISIKQAPRVGPAGEHRLVTVTRTDNQILEAEFPGLPEALSFVALVDGYFRLTTDSQHFFCKEVAPPRLLEEVAEQCHGPITLDFAINKLKTGGSRPGSYVLRRSPQDFDSFLLTVCVQNPLGPDYKGCLIRRSPTGTFLLVGLSRPHSSLRELLATCWDGGLHVDGVAVTLTSCCIPRPKEKSNLIVVQRGHSPPTSSLVQPQSQYQLSQMTFHKIPADSLEWHENLGHGSFTKIYRGCRHEVVDGEARKTEVLLKVMDAKHKNCMESFLEAASLMSQVSYRHLVLLHGVCMAGDSTMVQEFVHLGAIDMYLRKRGHLVPASWKLQVVKQLAYALNYLEDKGLPHGNVSARKVLLAREGADGSPPFIKLSDPGVSPAVLSLEMLTDRIPWVAPECLREAQTLSLEADKWGFGATVWEVFSGVTMPISALDPAKKLQFYEDRQQLPAPKWTELALLIQQCMAYEPVQRPSFRAVIRDLNSLISSDYELLSDPTPGALAPRDGLWNGAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 3PJC,5TOZ,5TTS,5TTU,5TTV,6DA4,6DB3,6DB4,6DUD,7C3N Tyrosine-protein kinase JAK3 JAK3_HUMAN P52333 Q13259 Q13260 Q13611 Q8N1E8 Q99699 Q9Y6S2 1071073 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52)/t32-,33?,34?,35+,36-,37-,39+,43-,44-,45-/m0/s1 HSRYETVWRVWJQQ-RTDIISPTSA-N 511486 US11059789, Example 19::US11691950, Example 19 Non-receptor tyrosine-protein kinase TYK2 Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4916&target=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Non-receptor+tyrosine-protein+kinase+TYK2&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQAQVWLPPNHILEIPRDASLMLYFRIRFYFRNWHGMNPREPAVYRCGPPGTEASSDQTAQGMQLLDPASFEYLFEQGKHEFVNDVASLWELSTEEEIHHFKNESLGMAFLHLCHLALRHGIPLEEVAKKTSFKDCIPRSFRRHIRQHSALTRLRLRNVFRRFLRDFQPGRLSQQMVMVKYLATLERLAPRFGTERVPVCHLRLLAQAEGEPCYIRDSGVAPTDPGPESAAGPPTHEVLVTGTGGIQWWPVEEEVNKEEGSSGSSGRNPQASLFGKKAKAHKAVGQPADRPREPLWAYFCDFRDITHVVLKEHCVSIHRQDNKCLELSLPSRAAALSFVSLVDGYFRLTADSSHYLCHEVAPPRLVMSIRDGIHGPLLEPFVQAKLRPEDGLYLIHWSTSHPYRLILTVAQRSQAPDGMQSLRLRKFPIEQQDGAFVLEGWGRSFPSVRELGAALQGCLLRAGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHNLADVLTVNPDSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPSVFSVC 3NZ0,3ZON,4PO6,4PY1,5C01,5C03,6DBK,6DBM,6VNS,6VNV,6VNX,6VNY,6X8F,6X8G,7AX4,7UYR,7UYS,7UYT,7UYU,8S98,8S99,8S9A Non-receptor tyrosine-protein kinase TYK2 TYK2_HUMAN P29597 Q6QB10 Q96CH0 1071074 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52)/t32-,33?,34?,35+,36-,37-,39+,43-,44-,45-/m0/s1 HSRYETVWRVWJQQ-RTDIISPTSA-N 511486 US11059789, Example 19::US11691950, Example 19 Inhibitor of nuclear factor kappa-B kinase subunit beta Homo sapiens 50000 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2933&target=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Inhibitor+of+nuclear+factor+kappa-B+kinase+subunit+beta&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS Inhibitor of nuclear factor kappa-B kinase subunit beta IKKB_HUMAN O14920 B4DZ30 B4E0U4 O75327 1071075 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58)/t32-,33+,34+,36+,37+,39-,44+,45+,46+,47-/m1/s1 QXQGSOMQKZFIRY-KUDXWLMMSA-N 511480 US11059789, Example 40::US11691950, Example 40 Protein kinase C alpha type Homo sapiens 190 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=599&target=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MADVFPGNDSTASQDVANRFARKGALRQKNVHEVKDHKFIARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPDTDDPRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGMDHTEKRGRIYLKAEVADEKLHVTVRDAKNLIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIRSTLNPQWNESFTFKLKPSDKDRRLSVEIWDWDRTTRNDFMGSLSFGVSELMKMPASGWYKLLNQEEGEYYNVPIPEGDEEGNMELRQKFEKAKLGPAGNKVISPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSVCKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKGAENFDKFFTRGQPVLTPPDQLVIANIDQSDFEGFSYVNPQFVHPILQSAV 4DNL,4RA4 Protein kinase C alpha type KPCA_HUMAN P17252 B5BU22 Q15137 Q32M72 Q96RE4 1071076 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58)/t32-,33+,34+,36+,37+,39-,44+,45+,46+,47-/m1/s1 QXQGSOMQKZFIRY-KUDXWLMMSA-N 511480 US11059789, Example 40::US11691950, Example 40 Protein kinase C delta type Homo sapiens 152 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK,2YUU,3UGD Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1071077 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58)/t32-,33+,34+,36+,37+,39-,44+,45+,46+,47-/m1/s1 QXQGSOMQKZFIRY-KUDXWLMMSA-N 511480 US11059789, Example 40::US11691950, Example 40 Protein kinase C epsilon type Homo sapiens 244 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1071078 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H51F2N3O10/c1-43(2)61-39-20-33-34-19-36(48)35-18-31(53)13-15-44(35,3)46(34,49)37(54)21-45(33,4)47(39,62-43)38(55)25-60-41(57)12-11-40(56)59-24-26-5-7-27(8-6-26)32(22-50)42(58)52-30-10-9-29-23-51-16-14-28(29)17-30/h5-10,13-18,23,32-34,36-37,39,54H,11-12,19-22,24-25,50H2,1-4H3,(H,52,58)/t32-,33+,34+,36+,37+,39-,44+,45+,46+,47-/m1/s1 QXQGSOMQKZFIRY-KUDXWLMMSA-N 511480 US11059789, Example 40::US11691950, Example 40 RAC-alpha serine/threonine-protein kinase Human 523 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511480&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146436505 459628738 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 1H10,1UNP,1UNQ,1UNR,2UVM,3O96,6BUU,6CCY,6NPZ RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1071079 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55)/t26-,34-,35+,36+,37+,42+,43+,44+,45+/m1/s1 LYJKMVFAIXOQLE-KFTDLJQOSA-N 511481 US11059789, Example 25::US11691950, Example 25 Protein kinase C alpha type Homo sapiens 173 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=599&target=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MADVFPGNDSTASQDVANRFARKGALRQKNVHEVKDHKFIARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPDTDDPRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGMDHTEKRGRIYLKAEVADEKLHVTVRDAKNLIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIRSTLNPQWNESFTFKLKPSDKDRRLSVEIWDWDRTTRNDFMGSLSFGVSELMKMPASGWYKLLNQEEGEYYNVPIPEGDEEGNMELRQKFEKAKLGPAGNKVISPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSVCKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKGAENFDKFFTRGQPVLTPPDQLVIANIDQSDFEGFSYVNPQFVHPILQSAV 4DNL,4RA4 Protein kinase C alpha type KPCA_HUMAN P17252 B5BU22 Q15137 Q32M72 Q96RE4 1071080 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55)/t26-,34-,35+,36+,37+,42+,43+,44+,45+/m1/s1 LYJKMVFAIXOQLE-KFTDLJQOSA-N 511481 US11059789, Example 25::US11691950, Example 25 Protein kinase C delta type Homo sapiens 225 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK,2YUU,3UGD Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1071081 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55)/t26-,34-,35+,36+,37+,42+,43+,44+,45+/m1/s1 LYJKMVFAIXOQLE-KFTDLJQOSA-N 511481 US11059789, Example 25::US11691950, Example 25 Protein kinase C epsilon type Homo sapiens 1578 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1071082 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H50FN3O9/c1-26-18-36-35-11-9-31-20-33(50)14-16-42(31,2)44(35,46)37(51)21-43(36,3)45(26,56)38(52)25-58-40(54)13-12-39(53)57-24-27-4-6-28(7-5-27)34(22-47)41(55)49-32-10-8-30-23-48-17-15-29(30)19-32/h4-8,10,14-17,19-20,23,26,34-37,51,56H,9,11-13,18,21-22,24-25,47H2,1-3H3,(H,49,55)/t26-,34-,35+,36+,37+,42+,43+,44+,45+/m1/s1 LYJKMVFAIXOQLE-KFTDLJQOSA-N 511481 US11059789, Example 25::US11691950, Example 25 RAC-alpha serine/threonine-protein kinase Human 955 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511481&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146436313 459628739 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 1H10,1UNP,1UNQ,1UNR,2UVM,3O96,6BUU,6CCY,6NPZ RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1071083 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55)/t25-,33-,34+,35+,36+,37+,42+,43+,44+,45+/m1/s1 NKWSAYGUIMPROA-PNSJQOAOSA-N 511482 US11059789, Example 83::US11691950, Example 83 Protein kinase C alpha type Homo sapiens 51.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=599&target=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MADVFPGNDSTASQDVANRFARKGALRQKNVHEVKDHKFIARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPDTDDPRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGMDHTEKRGRIYLKAEVADEKLHVTVRDAKNLIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIRSTLNPQWNESFTFKLKPSDKDRRLSVEIWDWDRTTRNDFMGSLSFGVSELMKMPASGWYKLLNQEEGEYYNVPIPEGDEEGNMELRQKFEKAKLGPAGNKVISPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSVCKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKGAENFDKFFTRGQPVLTPPDQLVIANIDQSDFEGFSYVNPQFVHPILQSAV 4DNL,4RA4 Protein kinase C alpha type KPCA_HUMAN P17252 B5BU22 Q15137 Q32M72 Q96RE4 1071084 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55)/t25-,33-,34+,35+,36+,37+,42+,43+,44+,45+/m1/s1 NKWSAYGUIMPROA-PNSJQOAOSA-N 511482 US11059789, Example 83::US11691950, Example 83 Protein kinase C delta type Homo sapiens 56.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK,2YUU,3UGD Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1071085 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55)/t25-,33-,34+,35+,36+,37+,42+,43+,44+,45+/m1/s1 NKWSAYGUIMPROA-PNSJQOAOSA-N 511482 US11059789, Example 83::US11691950, Example 83 Protein kinase C epsilon type Homo sapiens 154 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1071086 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C[C@H](N)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H51FN4O9/c1-25-16-35-34-11-9-30-18-32(51)12-14-42(30,2)44(34,46)37(52)20-43(35,3)45(25,57)38(53)24-58-39(54)19-36(48)41(56)59-23-26-4-6-27(7-5-26)33(21-47)40(55)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-37,52,57H,9,11,16,19-21,23-24,47-48H2,1-3H3,(H,50,55)/t25-,33-,34+,35+,36+,37+,42+,43+,44+,45+/m1/s1 NKWSAYGUIMPROA-PNSJQOAOSA-N 511482 US11059789, Example 83::US11691950, Example 83 RAC-alpha serine/threonine-protein kinase Human 95.0 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511482&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146423343 459628740 C03317 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 1H10,1UNP,1UNQ,1UNR,2UVM,3O96,6BUU,6CCY,6NPZ RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1071087 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57)/t28-,38-,39+,40+,41+,46+,47+,48+,49+/m1/s1 BJLOBSMGZUMYOP-WDNLRGLVSA-N 511483 US11059789, Example 66::US11691950, Example 66 Protein kinase C alpha type Homo sapiens 282 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=599&target=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MADVFPGNDSTASQDVANRFARKGALRQKNVHEVKDHKFIARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPDTDDPRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGMDHTEKRGRIYLKAEVADEKLHVTVRDAKNLIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIRSTLNPQWNESFTFKLKPSDKDRRLSVEIWDWDRTTRNDFMGSLSFGVSELMKMPASGWYKLLNQEEGEYYNVPIPEGDEEGNMELRQKFEKAKLGPAGNKVISPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSVCKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKGAENFDKFFTRGQPVLTPPDQLVIANIDQSDFEGFSYVNPQFVHPILQSAV 4DNL,4RA4 Protein kinase C alpha type KPCA_HUMAN P17252 B5BU22 Q15137 Q32M72 Q96RE4 1071088 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57)/t28-,38-,39+,40+,41+,46+,47+,48+,49+/m1/s1 BJLOBSMGZUMYOP-WDNLRGLVSA-N 511483 US11059789, Example 66::US11691950, Example 66 Protein kinase C delta type Homo sapiens 357 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK,2YUU,3UGD Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1071089 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57)/t28-,38-,39+,40+,41+,46+,47+,48+,49+/m1/s1 BJLOBSMGZUMYOP-WDNLRGLVSA-N 511483 US11059789, Example 66::US11691950, Example 66 Protein kinase C epsilon type Homo sapiens 3614 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1071090 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccc(cc1)C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C49H50FN3O9/c1-28-20-40-39-15-13-35-22-37(54)16-18-46(35,2)48(39,50)41(55)23-47(40,3)49(28,60)42(56)27-62-45(59)32-10-8-31(9-11-32)44(58)61-26-29-4-6-30(7-5-29)38(24-51)43(57)53-36-14-12-34-25-52-19-17-33(34)21-36/h4-12,14,16-19,21-22,25,28,38-41,55,60H,13,15,20,23-24,26-27,51H2,1-3H3,(H,53,57)/t28-,38-,39+,40+,41+,46+,47+,48+,49+/m1/s1 BJLOBSMGZUMYOP-WDNLRGLVSA-N 511483 US11059789, Example 66::US11691950, Example 66 RAC-alpha serine/threonine-protein kinase Human 1358 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511483&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146436137 459628741 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 1H10,1UNP,1UNQ,1UNR,2UVM,3O96,6BUU,6CCY,6NPZ RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1071091 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57)/t34-,35+,36+,37+,39-,44+,45+,46+,47-/m1/s1 SDZRYLPROGBZMB-UPVGTXGNSA-N 511484 US11059789, Example 33::US11691950, Example 33 Protein kinase C alpha type Homo sapiens 145 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=599&target=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MADVFPGNDSTASQDVANRFARKGALRQKNVHEVKDHKFIARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPDTDDPRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGMDHTEKRGRIYLKAEVADEKLHVTVRDAKNLIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIRSTLNPQWNESFTFKLKPSDKDRRLSVEIWDWDRTTRNDFMGSLSFGVSELMKMPASGWYKLLNQEEGEYYNVPIPEGDEEGNMELRQKFEKAKLGPAGNKVISPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSVCKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKGAENFDKFFTRGQPVLTPPDQLVIANIDQSDFEGFSYVNPQFVHPILQSAV 4DNL,4RA4 Protein kinase C alpha type KPCA_HUMAN P17252 B5BU22 Q15137 Q32M72 Q96RE4 1071092 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57)/t34-,35+,36+,37+,39-,44+,45+,46+,47-/m1/s1 SDZRYLPROGBZMB-UPVGTXGNSA-N 511484 US11059789, Example 33::US11691950, Example 33 Protein kinase C delta type Homo sapiens 142 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK,2YUU,3UGD Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1071093 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57)/t34-,35+,36+,37+,39-,44+,45+,46+,47-/m1/s1 SDZRYLPROGBZMB-UPVGTXGNSA-N 511484 US11059789, Example 33::US11691950, Example 33 Protein kinase C epsilon type Homo sapiens 1575 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1071094 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)COC(=O)CCC(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C47H52FN3O10/c1-43(2)60-39-21-36-35-12-10-31-20-33(52)15-17-44(31,3)46(35,48)37(53)22-45(36,4)47(39,61-43)38(54)26-59-41(56)14-13-40(55)58-25-27-5-7-28(8-6-27)34(23-49)42(57)51-32-11-9-30-24-50-18-16-29(30)19-32/h5-9,11,15-20,24,34-37,39,53H,10,12-14,21-23,25-26,49H2,1-4H3,(H,51,57)/t34-,35+,36+,37+,39-,44+,45+,46+,47-/m1/s1 SDZRYLPROGBZMB-UPVGTXGNSA-N 511484 US11059789, Example 33::US11691950, Example 33 RAC-alpha serine/threonine-protein kinase Human 1243 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511484&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146436321 459628742 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 1H10,1UNP,1UNQ,1UNR,2UVM,3O96,6BUU,6CCY,6NPZ RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1071095 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54)/t25-,33?,34?,35-,36+,37+,38+,43+,44+,45+,46+/m1/s1 NZTPJNIILSLMRH-XGTQYUGGSA-N 511485 US11059789, Example 27::US11691950, Example 27 Protein kinase C alpha type Homo sapiens 331 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=599&target=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MADVFPGNDSTASQDVANRFARKGALRQKNVHEVKDHKFIARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPDTDDPRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGMDHTEKRGRIYLKAEVADEKLHVTVRDAKNLIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIRSTLNPQWNESFTFKLKPSDKDRRLSVEIWDWDRTTRNDFMGSLSFGVSELMKMPASGWYKLLNQEEGEYYNVPIPEGDEEGNMELRQKFEKAKLGPAGNKVISPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSVCKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKGAENFDKFFTRGQPVLTPPDQLVIANIDQSDFEGFSYVNPQFVHPILQSAV 4DNL,4RA4 Protein kinase C alpha type KPCA_HUMAN P17252 B5BU22 Q15137 Q32M72 Q96RE4 1071096 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54)/t25-,33?,34?,35-,36+,37+,38+,43+,44+,45+,46+/m1/s1 NZTPJNIILSLMRH-XGTQYUGGSA-N 511485 US11059789, Example 27::US11691950, Example 27 Protein kinase C delta type Homo sapiens 509 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK,2YUU,3UGD Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1071097 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54)/t25-,33?,34?,35-,36+,37+,38+,43+,44+,45+,46+/m1/s1 NZTPJNIILSLMRH-XGTQYUGGSA-N 511485 US11059789, Example 27::US11691950, Example 27 Protein kinase C epsilon type Homo sapiens 3455 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1071098 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C46H50FN3O9/c1-25-16-37-36-11-9-30-18-32(51)12-14-43(30,2)45(36,47)38(52)20-44(37,3)46(25,57)39(53)24-59-42(56)34-19-33(34)41(55)58-23-26-4-6-27(7-5-26)35(21-48)40(54)50-31-10-8-29-22-49-15-13-28(29)17-31/h4-8,10,12-15,17-18,22,25,33-38,52,57H,9,11,16,19-21,23-24,48H2,1-3H3,(H,50,54)/t25-,33?,34?,35-,36+,37+,38+,43+,44+,45+,46+/m1/s1 NZTPJNIILSLMRH-XGTQYUGGSA-N 511485 US11059789, Example 27::US11691950, Example 27 RAC-alpha serine/threonine-protein kinase Human 2641 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511485&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146436160 459628743 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 1H10,1UNP,1UNQ,1UNR,2UVM,3O96,6BUU,6CCY,6NPZ RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1071099 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52)/t32-,33?,34?,35+,36-,37-,39+,43-,44-,45-/m0/s1 HSRYETVWRVWJQQ-RTDIISPTSA-N 511486 US11059789, Example 19::US11691950, Example 19 Protein kinase C alpha type Homo sapiens 436 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=599&target=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Protein+kinase+C+alpha+type&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MADVFPGNDSTASQDVANRFARKGALRQKNVHEVKDHKFIARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPDTDDPRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGMDHTEKRGRIYLKAEVADEKLHVTVRDAKNLIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIRSTLNPQWNESFTFKLKPSDKDRRLSVEIWDWDRTTRNDFMGSLSFGVSELMKMPASGWYKLLNQEEGEYYNVPIPEGDEEGNMELRQKFEKAKLGPAGNKVISPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSVCKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKGAENFDKFFTRGQPVLTPPDQLVIANIDQSDFEGFSYVNPQFVHPILQSAV 4DNL,4RA4 Protein kinase C alpha type KPCA_HUMAN P17252 B5BU22 Q15137 Q32M72 Q96RE4 1071100 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52)/t32-,33?,34?,35+,36-,37-,39+,43-,44-,45-/m0/s1 HSRYETVWRVWJQQ-RTDIISPTSA-N 511486 US11059789, Example 19::US11691950, Example 19 Protein kinase C delta type Homo sapiens 589 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=603&target=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Protein+kinase+C+delta+type&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED 1YRK,2YUU,3UGD Protein kinase C delta type KPCD_HUMAN Q05655 B0KZ81 B2R834 Q15144 Q86XJ6 1071101 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52)/t32-,33?,34?,35+,36-,37-,39+,43-,44-,45-/m0/s1 HSRYETVWRVWJQQ-RTDIISPTSA-N 511486 US11059789, Example 19::US11691950, Example 19 Protein kinase C epsilon type Homo sapiens 4163 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=604&target=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=Protein+kinase+C+epsilon+type&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIELAVFHDAPIGYDDFVANCTIQFEELLQNGSRHFEDWIDLEPEGRVYVIIDLSGSSGEAPKDNEERVFRERMRPRKRQGAVRRRVHQVNGHKFMATYLRQPTYCSHCRDFIWGVIGKQGYQCQVCTCVVHKRCHELIITKCAGLKKQETPDQVGSQRFSVNMPHKFGIHNYKVPTFCDHCGSLLWGLLRQGLQCKVCKMNVHRRCETNVAPNCGVDARGIAKVLADLGVTPDKITNSGQRRKKLIAGAESPQPASGSSPSEEDRSKSAPTSPCDQEIKELENNIRKALSFDNRGEEHRAASSPDGQLMSPGENGEVRQGQAKRLGLDEFNFIKVLGKGSFGKVMLAELKGKDEVYAVKVLKKDVILQDDDVDCTMTEKRILALARKHPYLTQLYCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTSALMFLHQHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPHKRLGCVASQNGEDAIKQHPFFKEIDWVLLEQKKIKPPFKPRIKTKRDVNNFDQDFTREEPVLTLVDEAIVKQINQEEFKGFSYFGEDLMP Protein kinase C epsilon type KPCE_HUMAN Q02156 B0LPH7 Q32MQ3 Q53SL4 Q53SM5 Q9UE81 1071102 C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)C1CC1C(=O)OCc1ccc(cc1)[C@@H](CN)C(=O)Nc1ccc2cnccc2c1 InChI=1S/C45H49N3O9/c1-43-14-11-31(49)18-29(43)8-10-32-36-12-15-45(55,44(36,2)20-37(50)39(32)43)38(51)24-57-42(54)34-19-33(34)41(53)56-23-25-3-5-26(6-4-25)35(21-46)40(52)48-30-9-7-28-22-47-16-13-27(28)17-30/h3-7,9,11,13-14,16-18,22,32-37,39,50,55H,8,10,12,15,19-21,23-24,46H2,1-2H3,(H,48,52)/t32-,33?,34?,35+,36-,37-,39+,43-,44-,45-/m0/s1 HSRYETVWRVWJQQ-RTDIISPTSA-N 511486 US11059789, Example 19::US11691950, Example 19 RAC-alpha serine/threonine-protein kinase Human 2540 US Patent 10.7270/Q2VD72M2 aid1805779 US11059789 deLong, MA; Carlson, E; Kopczynski, C; Sturdivant, JM; Lichorowic, C 7/13/2021 1/23/2022 Aerie Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=511486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=513&target=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=511486&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 146436141 459628744 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA 1H10,1UNP,1UNQ,1UNR,2UVM,3O96,6BUU,6CCY,6NPZ RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6